Maintenance therapy with pemetrexed plus best supportive care versus placebo plus best supportive care after induction therapy with pemetrexed plus cisplatin for advanced non-squamous non-small-cell lung cancer (PARAMOUNT): a double-blind, phase 3, randomised controlled trial

Details 詳細情報について

• CRID

  1362544418886534912

• DOI

  10.1016/s1470-2045(12)70063-3

• ISSN

  14702045

• Web Site

  https://api.elsevier.com/content/article/PII:S1470204512700633?httpAccept=text/xml

  https://api.elsevier.com/content/article/PII:S1470204512700633?httpAccept=text/plain

• Data Source

  • Crossref